Frontlight ResearchEarly access
Fatty liver disease (MASLD/MASH) trials in South Korea
4 of 14 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEstablishment of NAFLD Cohort and Development of Fibrosis Markers
- Where
- Seoul
- Age
- 18 years and over
- People
- 1,000
- Run by
- Seoul National University Boramae Hospital
See details and how to joinNCT02206841 - No phaseTaking peopleLiver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
- Where
- Daejeon
- Age
- 19 years and over
- People
- 3,000
- Run by
- Chungnam National University Hospital
See details and how to joinNCT06519162 - No phaseNot yet taking people in South KoreaKorean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
- Where
- Gangwon-do, Gyeonggi-do, Seoul, Suwon, Yongin
- Age
- 19 years and over
- People
- 6,000
- Run by
- Korea University
See details and how to joinNCT06843421 - No phaseTaking peopleA Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
- Where
- Andong, Seoul
- Age
- 19 years and over
- People
- 10,000
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06649162